Survodutide - Novel Anti Obesity Drug
Survodutide (BI 456906) is a novel, dual agonist of glucagon and glucagon-like peptide-1 (GLP-1) receptors developed as a once-weekly subcutaneous injection for the management of obesity. While GLP-1 receptor agonists have shown promise in managing obesity and associated complications, survodutide...
Spremljeno u:
| Glavni autori: | , , , , |
|---|---|
| Format: | Artigo |
| Jezik: | Inglês |
| Izdano: |
Dr. Annil Mahajan
2025-01-01
|
| Serija: | JK Science |
| Teme: | |
| Online pristup: | https://journal.jkscience.org/index.php/JK-Science/article/view/344 |
| Oznake: |
Bez oznaka, Budi prvi tko označuje ovaj zapis!
|